NAV
$126.17
AUM
$874.1M
Expense Ratio
-
Dividend Yield
0.81%
Beta
0.84
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +10.88% | +8.21% | +14.14% | +24.01% | +6.12% | +1.62% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | OGN | Organon & Co Ordinary Shares | 3.78% |
| 2 | HUM | Humana Inc | 3.74% |
| 3 | ELV | Elevance Health Inc | 2.85% |
| 4 | DVA | DaVita Inc | 2.68% |
| 5 | EXEL | Exelixis Inc | 2.50% |
| 6 | SOLV | Solventum Corp | 2.44% |
| 7 | BIO | Bio-Rad Laboratories Inc Class A | 2.38% |
| 8 | BIIB | Biogen Inc | 2.27% |
| 9 | MOH | Molina Healthcare Inc | 2.21% |
| 10 | CI | The Cigna Group | 2.21% |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.
Inception Date: 2007-05-08